U.S. Adderall shortages could resolve in the coming weeks

[Image courtesy of Patrick Mallahan III via the Creative Commons Attribution]

Generic versions of the Takeda’s (NYSE:TAK) ADHD drug Adderall (amphetamine and dextroamphetamine) continue to be in short supply as demand for it has surged. Both instant-release and extended-release versions of mixed amphetamine salts have been affected by the shortages.

A central supplier of the drug in the U.S., Teva (NYSE:TEVA), says labor shortages related to packaging of the drug are partly to blame for the shortage. Novartis subsidiary Sandoz is also has experienced manufacturing shortages related to the drug.

During the pandemic, the federal government loosened rules calling for an in-person visit to obtain Adderall and generic equivalents. The government made it possible to prescribe the drug via telehealth.

An August pharmacists’ survey revealed that approximately 64% of U.S. pharmacies encountered difficult…

Read more
  • 0